Skip to content

Study on the effect of a nutritional supplement on intestinal microbiota and nutritional status of chronic kidney disease patients.

Exploratory study on the effect of a nutritional supplement on intestinal microbiota and nutritional status of chronic kidney disease patients. - Exploratory study on the effect of a nutritional supplement on intestinal microbiota and nutritional status of chronic kidney disease patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056197
Enrollment
40
Registered
2024-11-19
Start date
2024-11-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Taking orally one pack of nutritional supplement (150 kcal) per day for 6 weeks

Sponsors

Bousei Nishi-Shinjuku Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Chronic kidney disease patients aged 20 or more undergoing outpatient care. (2) Patients in the advanced chronic kidney disease (stage??>=??3b) or on hemodialysis

Exclusion criteria

Exclusion criteria: (1) Persons who regularly use antibiotics or active biologic agents (2) Persons who regularly use health foods or supplements that improve bowel movements (lactic acid bacteria, bifidobacteria, oligosaccharides, dietary fiber, etc.) (3) Persons with a history of gastrointestinal resection (3) Persons with a history of gastrointestinal resection (4) Persons who have allergic symptoms due to intake of milk or soy-derived ingredients (5) Persons who experience abdominal symptoms such as diarrhea upon ingestion of dairy products (6) Persons who are participating in other clinical trials (7) Persons who are judged to be unsuitable as subjects by the study director due to subject background, lifestyle, etc.

Design outcomes

Primary

MeasureTime frame
Stool-related indicators (fecal microbiota, organic acids, putrefactive products, pH), defecation habits (frequency, number of days, and type of shape), body weight, clinical laboratory indicators (hematological and blood biochemical indicators)

Countries

Japan

Contacts

Public ContactKazuma Yoshida

Morinaga Milk Industry Co., Ltd. Health Care & Nutritional Science Institute, R&D Division

kazuma-yoshida693@morinagamilk.co.jp046-252-3057

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026